The S&P 500 climbed 0.4% to 3,716.77 in midday trading.
The Dow Jones Industrial Average increased 0.4% to 30,259.89 while the Nasdaq rose 0.7% to 12,742.41.
The yield on a 10-year Treasury bond ticked up 2.2% to 0.94%.
Oil climbed 0.9% to $48.26.
The price of gold rose 1.8% to $1,891.90 per ounce.
HEALTHCARE
Newport Beach-based Evolus Inc. (Nasdaq: EOLS) climbed 18% to $4.34 a share at midday trading with a $146 million market cap. Evolus announced yesterday its flagship Jeuveau aesthetic product received a more favorable ruling from the U.S. International Trade Commission.
The ITC reversed a lower judge’s ruling that Evolus violated a trade secret involving rival South Korean companies and Allergan, now a unit of AbbVie. The ITC also reduced the judge’s recommendation for a 10-year ban to 21 months.
ClearPoint Neuro Inc. (Nasdaq: CLPT) of Irvine jumped 8% to $11.55 and a $194 million market cap. Shares of the medical device maker for neurological disorders are up more than twofold since the beginning of the year. Analysts expect the company’s annual revenue to jump about 10% to 12.2 million this year.
